UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, ~~D.C.~~DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(Dd) OF THE

~~THE~~ SECURITIES EXCHANGE ACT OF 1934

Date of ~~Report~~report (Date of earliest event reported): ~~June~~August 2515, 2013

BAHAMAS CONCIERGE, INC.

(Exact Name of Registrant as Specified in Charter)

Nevada	333-176048	90-0724671
(State or other jurisdiction	(Commission File Number)	(IRS Employer
of Incorporation)		Identification Number)

Nevada
(State or other jurisdiction	(Commission File Number)	(IRS Employer
of Incorporation)		Identification Number)

8076 Buttonwood Circle

8076 Buttonwood Circle Tamarac, FL	33321
(Address of Principal Executive Offices)	(Zip Code)

~~Tamarac~~Registrant’s telephone number, FLincluding ~~33321~~area code: (954) 295-9754

~~(Address~~Registrant’s offacsimile ~~principal~~number, ~~executive~~including ~~offices~~area code: (877) 895-5647

~~(954)~~Not ~~295-9754~~Applicable

(~~Registrant’s~~Former ~~telephone~~name ~~number~~or former address, if changed since last report)

Check the appropriate box ~~below~~ if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: (see General Instruction A.2, below);

. ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

. ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

. ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

. ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~BAHAMAS~~Item 4.01 Changes ~~CONCIERGE,~~in ~~INC.~~Registrant’s Certifying Accountant

~~Form~~(a) Resignation ~~8-K~~of Sadler, Gibb & Associates, LLC.

~~Current~~(i) Effective ~~Report~~August 15, 2013, Bahamas Concierge, Inc. (the “Company”) accepted the resignation of Sadler, Gibb & Associates, LLC (“Sadler”) as its principal independent registered public accounting firm. The decision to accept the resignation of Sadler was approved by the Company’s board of directors.

~~Item~~(ii) The ~~5.01~~report ~~Change~~of inSadler ~~Control~~on the Company’s financial statements for the fiscal years ended May 31, 2012 and 2011, did not contain an adverse opinion or disclaimer of ~~Registrant~~opinion, nor was it modified as to uncertainty, audit scope or accounting principles.

On(iii) During ~~June~~the 25fiscal years ended May 31, ~~2013~~2012 and 2011 and during the subsequent period through to the date of Sadler’s resignation, ~~Nina~~there ~~Goldstein~~were ~~purchased~~no 4disagreements between the Company and Sadler,~~500~~ whether or not resolved,~~000~~ ~~shares~~on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to the ~~Company's~~satisfaction ~~stock~~of ~~from~~Sadler, ~~David~~would ~~Williams~~have caused Sadler to make reference thereto in ~~exchange~~its ~~for~~report ~~$22,500~~on the Company’s audited financial statements.~~00.~~ ~~This~~In ~~represents~~connection ~~approximately~~with ~~89%~~the audits of the ~~issued~~fiscal ~~and~~years ~~outstanding~~ended ~~shares~~May of31, 2012 and 2011 and the ~~Company~~subsequent interim period through August 15, 2013, there have been no “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K).

~~Item~~(iv) The ~~5.02~~Company ~~Departure~~provided Sadler with a copy of ~~Directors~~this Current Report on Form 8-K and has requested that Sadler furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether or ~~Principal~~not ~~Officers;~~Sadler ~~Election~~agrees ofwith ~~Directors;~~the ~~Appointment~~statements made in this Current Report on Form 8-K with respect to Sadler and, if not, stating the aspects with which they do not agree. The Company has received the requested letter from Sadler wherein they have confirmed their agreement to the Company’s disclosures in this Current Report with respect to Sadler. A copy of ~~Principal~~Sadler's ~~Officers~~letter has been filed as an exhibit to this Current Report on Form 8-K.

~~Appointment~~(b) Engagement of ~~Sondra~~M&K ~~Trust~~CPAS, ~~R.N., B.S. as our Chief Executive Officer and Director~~PLLC

On(i) Effective ~~June~~August 2515, 2013, the ~~Board~~Company ~~appointed~~engaged ~~Sondra~~M&K ~~Trust~~CPAS, ~~R.N.,~~PLLC ~~B.S.~~(“M&K”) toas bethe aCompany’s ~~Director~~independent onregistered ~~the~~public ~~Board~~accounting ~~and~~firm. toThe ~~act~~engagement aswas approved by the Company'’s ~~Chief~~board ~~Executive~~of ~~Officer and President~~directors.

~~Appointment~~(ii) In ofconnection ~~Nina~~with ~~Goldstein.~~the Company’s appointment of M&K as ~~our~~the ~~Chief~~Company’s ~~Financial~~independent ~~Officer~~registered ~~and~~accounting ~~Chairperson~~firm, the Company has not consulted Sadler on any matter relating to the application of accounting principles to a specific transaction, either completed or contemplated, or the ~~Board~~type of audit opinion that might be rendered on the Company’s financial statements.

OnItem ~~June 25, 2013 the Board appointed Nina Goldstein to be the Chairperson of the Board and to act as the Company's Chief~~ 9.01 Financial ~~Officer~~Statements and ~~Secretary.~~Exhibits

~~Resignation of David Williams~~(a) Exhibits

OnExhibit ~~June 25, 2013, the Board accepted the resignation of David Williams~~No. ~~Mr. William's resignation as a Director and Officer of the Company was not regarding any matter pertaining to our operations, policies or practices.~~ Description

~~Biographical~~16.1 Letter ~~Information~~from ~~Pertaining~~Sadler, toGibb ~~Sondra~~& ~~Trust~~Associates, RLLC.N., ~~B.S.~~ as ~~our~~to ~~Chief~~change ~~Executive~~in ~~Officer~~certifying ~~and Director~~accountant.

From 2008 to present, Ms. Trust has been an Infusion Nurse Consultant to multiple home infusion therapy companies, specializing in intravenous administration of biological drugs and chemotherapy. From 1997 to present, Ms. Trust has been the President of International Healthcare Recruiters, Inc., specializing in the recruitment and placement of foreign and domestic healthcare professionals. Ms. Trust holds a BS in Nursing as Suma Cum Laude from Florida International University.SIGNATURE

NoPursuant ~~Arrangements~~to orthe ~~Understandings~~requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

~~There~~BAHAMAS ~~are~~CONCEIRGE, ~~no arrangements or understandings pursuant to which Ms~~INC. ~~Trust~~By: ~~was~~/s/ ~~appointed~~Nina byGoldstein ~~our~~Nina ~~Board~~Goldstein, ~~of Directors as our~~ Chief ~~Executive~~Financial Officer ~~and Director.~~

NoDated: ~~Family~~August ~~Relationships~~29, 2013

~~There are no family arrangements between Ms. Trust and any of our other officer or directors or any person or entity affiliated with us.~~3

No Involvement in Certain Legal Proceedings.

Over the past 10 years, Ms. Trust has not: (a) been involved as a general partner or executive officer of any business, which has filed a bankruptcy petition; (b) been convicted in a criminal proceeding or a named subject of a pending criminal proceeding; (c) been found in a court, the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law; (d) been the subject of any order, judgment or decree, permanently or temporarily enjoining her from or otherwise limiting, the following activities: (i) acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction, merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity; (ii) engaging in any type of business practice; or engaging in any activity in connection with any violation of federal or state securities laws or federal commodities laws. Further, Ms. Trust has never been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding relating to an alleged violation of any federal or state securities or commodities law or regulation; or any law or regulation respecting financial institutions or insurance companies, including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease and desist order, or removal or prohibition order; or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity.

Biographical Information Pertaining to Nina Goldstein. as our Chief Financial Officer and Chairperson of the Board

From 2003 to present, Ms. Goldstein has been the Director of Marketing for Nutra Pharma Corporation - a publicly traded biotechnology company with products for the treatment of Multiple Sclerosis, HIV and Pain. Through her involvement with Nutra Pharma, she has been responsible for the creative process for packaging design, ad creation and placement. Prior to 2003, Ms. Goldstein worked as an assistant merchandise manager for a consumer electronics retailer and was responsible for inventory management, merchandising and marketing for a category that produced in excess of ninety million dollars in revenue.

No Arrangements or Understandings

There are no arrangements or understandings pursuant to which Ms. Goldstein was appointed by our Board of Directors as our Chief Financial Officer and Director.

No Family Relationships

There are no family arrangements between Ms. Goldstein and any of our other officer or directors or any person or entity affiliated with us.

No Involvement in Certain Legal Proceedings.

Over the past 10 years, Ms. Goldstein has not: (a) been involved as a general partner or executive officer of any business, which has filed a bankruptcy petition; (b) been convicted in a criminal proceeding or a named subject of a pending criminal proceeding; (c) been found in court, the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law; (d) been the subject of any order, judgment or decree, permanently or temporarily enjoining her from or otherwise limiting, the following activities: (i) acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction, merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity; (ii) engaging in any type of business practice; or engaging in any activity in connection with any violation of federal or state securities laws or federal commodities laws. Further, Ms. Goldstein has never been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding relating to an alleged violation of any federal or state securities or commodities law or regulation; or any law or regulation respecting financial institutions or insurance companies, including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease and desist order, or removal or prohibition order; or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: July 25, 2013	BAHAMAS CONCIERGE, INC.
	By: /s/ Sondra Trust
	Sondra Trust President, Chief Executive Officer, Director

Filing Compare · BAHAMAS CONCIERGE, INC.